Use of rituximab and the risk of adverse clinical outcomes in COVID-19 patients with systemic rheumatic disease

Lignende værker

• Pharmacotherapeutic considerations for systemic rheumatic diseases amid the COVID-19 pandemic: more questions than answers
  af: Kow, Chia Siang, et al.
  Udgivet: (2020)
• Are severe asthma patients at higher risk of developing severe outcomes from COVID‐19?
  af: Kow, Chia Siang, et al.
  Udgivet: (2020)
• Quality of adverse event reporting in clinical trials of remdesivir in patients with COVID-19
  af: Kow, Chia Siang, et al.
  Udgivet: (2020)
• The Association Between the Use of Statins and Clinical Outcomes in Patients with COVID-19: A Systematic Review and Meta-analysis
  af: Kow, Chia Siang, et al.
  Udgivet: (2021)
• Role of frailty in COVID-19 patients
  af: Kow, Chia Siang, et al.
  Udgivet: (2020)